Chlamydia trachomatis infection in sexually active teenagers;Zakażenie Chlamydia trachomatis u aktywnych seksualnie nastolatek

Ginekologia Polska

Volumn 79, Issue 4, 2008, Pages 264-270

  Filipp, Ewa ^a   Niemiec, Krzysztof Tomasz ^a   Kowalska, Bozena ^a   Pawłowska, Adriana ^a   Kwiatkowska, Monika ^a  

^a INSTITUTE OF MOTHER AND CHILD   (Poland)

Author keywords

Adolescents; Chlamydia infections; Chlamydia trachomatis; Sexually transmitted diseases

Indexed keywords

ADOLESCENT; ARTICLE; ATTITUDE TO HEALTH; CHILD BEHAVIOR; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DISEASE TRANSMISSION; FEMALE; HUMAN; ISOLATION AND PURIFICATION; POLAND; PREVALENCE; PRIMARY PREVENTION; PSYCHOLOGICAL ASPECT; RISK FACTOR; SAFE SEX; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; STATISTICS; UNSAFE SEX; WOMEN'S HEALTH;

ADOLESCENT; ADOLESCENT BEHAVIOR; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; POLAND; PREVALENCE; PRIMARY PREVENTION; RISK FACTORS; SAFE SEX; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; UNSAFE SEX; WOMEN'S HEALTH;

EID: 47749144302     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Hills S, Nakashima A, Marchbanks P. [et al.]. Risks factors for current Chlamydia trachomatis infections in women. Am J Obstet Gynecol. 1994, 170, 3, 801-806.
2. Mosure D, Berman S, Kleinbaum D, [et al.]. Predictors of Chlamydia trachomatis infection among female adolescents: a longitudinal analysis. Am Journal Epidemiol 1996, 144, 997-1003.
3. Burstein G, Gaydos C, Diener-West M, [et al.]. Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA. 1998, 280, 521-526.
4. Cohen D, Nsuami M, Martin D, [et al.]. Repeated school-based screening for sexually transmitted diseases: a feasible strategy for reaching adolescents. Pediatrics. 1999, 104, 1281-1285.
5. McIlhaney J. Sexually transmited infection and teenage sexuality. Am J Obstet Gynecol. 2000, 183, 334-339.
6. Fortenberry J, Brizendine E, Katz B, [et al.]. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis. Sex Transm Dis. 1999, 26, 26-32.
7. Katz B, Fortenberry J, Tu W, [et al.]. Sexual behaviour among adolescent women at high risk for sexually transmitted infections. Sex Transm Dis. 2001, 28, 247-251.
8. Williams H, Tabrizi S, Lee W, [et al.]. Adolescence and other risk factors for Chlamydia trachomatis genitourinary infection in women in Melbourne, Australia. Sex Transm Infect. 2003, 79, 31-34.
9. Eng T, Butler W. The hidden epidemic: Confronting sexually transmitted disease. eds. Eng T, Butler W. Washington: Institute of Medicine, National Academy Press, 1997, 2-6
10. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004, 36, 6-10.
11. Wilson J, Honey E, Templeton A, [et al.]. A systematic review of the prevalence of Chlamydia trachmatis among European women. Hum Reprod Update. 2002, 8, 385-394.
12. Zabielski S, Antiszko M, Raczka A, [et al.]. The use of the Hybride Capture System II test in the diagnosis of mildly manifested and asymptomatic urethritis (NGU) caused by Chlamydia. Nowa Medycyna - Dermatologia. 2002, 116, 3-4.
13. Zdrodowski-Stefanow B, Mańkowska-Lesińska W. Epidemiologic and clinical studies of Chlamydia trachomatis infection in northern Poland. Sex. Transm. Dis. 1988, 15, 137-140.
14. Choroszy-Król I, Riczkowska J. Frequency of Chlamydia trachomatis infection in women in lower Silecia region of Poland 1999-2000. Med Wiek Rozw. 2002, 3, Suppl. 1, 57-64.
15. Friedek D, Ekiel A, Romanik M, [i wsp.]. Zakażenia Chlamydia trachomatis i wirusem brodawczaka ludzkiego u nastoletnich dziewczat. Ginekol Pol. 2005, 76, 879-883.
16. Teran S, Walsh C, Inwin K. Chlamydia trachomatis infection in women: bad news, good news and next steps in prevention. J Am Med Women Assos. 2001, 56, 100-104.
17. Stamm W, Holmes K. Chlamydia trachomatis infections of the adult. In: Sexually Transmitted Diseases 2nd. eds. Holmes K, Mardh P, sparling P, [et al.], New York: Mc Graw-Hill Information Services. 1990, 181-193.
18. Osborne N., Mucopurulent cervicitis. Contemporary Obstet Gynecol. 2001, 46, 64-68.
19. Brunham R, Paavonen J, Steven C, [et al.]. Mucopurulent cervicitis-the ignored counterpart in women of urethritis of men. N Engl J Med. 1984, 311, 1-6.
20. Henry-Suchet J, Utzmann Ch, De Brux J, [et al.]. Microbiologic study of chronic inflamation associated with tubal factor infertility: role of Chlamydia trachomatis. Fertil Steril. 1987, 47, 274-277.
21. Blythe M, Katz B, Orr D, [et al.]. Historical and clinical factors associated with Chlamydia trachomatis genitourinary infection in female adolescents. J Pediatr. 1988, 112, 1000-1004.
22. Lehmann M, Groh A, Rodel J, [et al.]. Detection of Chlamydia tracchomatis DNA in cervical samples with regard to infection by human papillomavirus. J Infect. 1999, 38, 12-17.
23. Wallin K, Wiklund F, Luostarinen T, [et al.]. A population-based prospective sudy of Chlmydia trachomatis infection and cervical carcinoma. Int J Cancer. 2002, 101, 371-374.
24. de Sanjoes S, Munoz N, Bosch F, [et al.]. Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer. 1994, 56, 358-363.
25. Markowska J. Rola zakażenia Chlamydia trachomatis w rozwoju CIN i raka szyjki macicy. Ginekol Pol. 2002, 73, 472-476.
26. Zbroch T, Knapp P, Błońska E, [i wsp.]. Wpływ zakażenia Chlamydia trachomatis i Bacterial vaginosis oraz stylu życia na wystepowanie zmian szyjki macicy. Ginekol Pol. 2004, 75, 538-544.
27. CDC Divisions of Sexually Transmitted Diseases Prevention 2002, Sexually Transmitted Diseases Treatment Guidelines 2002, MMWR (Recomendations and Reports). 2002, 51, RR 06, 1-80.
28. Niemiec K, Brazert J, Drews K, [i wsp.]. Recomendacje PTG dotyczace zakażeń Chlamydia trachomatis w położnictwie i ginekologii, Ginekol Pol. 2007, 78, 574-575.
29. Vuylsteke B, Vandenbruaene M, Vandenbalcke P, [et al.]. Chlamydia trachomatis prevalence and sexual behaviour among female adolescents in Belgium. Sex Transm Infect. 1999, 75, 152-155.
30. Paavonen J, Vesterinen E. Chlamydia trachomatis in cervitics and urethritis in women. Scand J. Infect Dis Suppl. 1982, 32, 45-54.
31. James N, Hughes S, Ahmed-Jushuf I, [et al.]. A collaborative approach to management of chlamydia infection among teenagers seeking contraceptive care in community setting. Sex Transm Infect. 1999, 75, 156-161.
32. Krikwood K, Horn K, Glasier A, [et al.]. Non-invasive screening of teenagers for Chlamydia trachomatis in a family planning setting. Br J Fam Plann. 1999, 25, 11-12.
33. Moller J, Andersen B, Olesen F, [et al.]. Reasons for Chlamydia trachomatis testing and the associated age-specific prevalences. Scand J Clin Lab Invest. 2003, 63, 339-345.
34. Grun L, Tassano-Smith J, Carder C, [et al.]. Comparison of two methods of screening for genital chlamydia infection in women attending in general practice: cross sectional survey. BMJ. 1997, 315, 226-230.
35. Siedlecki L. Risk factors for Chlamydia trachomatis genital infection in adolescent females. 8th Congress of The European Society of Contraception. Europ J Contracept Reprod Health Care. 2004, 1, 9, 1.
36. van Bergen J, Gots H, Richardus J, [et al.]. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanization and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect. 2005, 81, 17-23.
37. van Duynhoven Y, Ossewaarde J, Derksen-Nawrocki R, [et al.]. Chlamydia trachomatis genotypes: correlation with clinical manifestations on infection and patients' charateristics. Clin Infect Dis. 1998, 26, 314-322.
38. van Valkengoed I, Morre S, van den Brule A. Low diagnostic accuracy of selective screening criteria for asymptomatic Chlamydia trachomatis infections in the general population. Sex Transm Infect. 2000, 76, 375-380.
39. Chacko M, Lowchik J. Chlamydia trachomatis infection in sexually active adolescents: prevalence and risk factors. Pediatrics. 1984, 73, 836-840.
40. Feldmann J, Middleman A. Adolescent sexually and sexual behaviour. Cur Opin Obstet Gynecol. 2002, 14, 489-493.
41. Jones C, Knaup R, Hayes M, [et al.]. Urine screening for gonococcal and chlamydial infections at community-based organizations in a high-morbidity area. sex Transm Dis. 2000, 27, 146-151.
42. Williams H, Tabrizi S, Lee W, [et al.]. Adolescence and other risk factors for Chlamydia trachomatis genitourinary infection in women in Melboure, Australia. Sex Transm Infect. 2003, 79, 31-34.
43. Woynarowska B, Szymańska M, Mazur J. Wiedza i przekonania o HIV/ AIDS. Zachowania seksualne. Raport z badań wykonanych w 1998 roku. Warszawa, 1999, 41-42.
44. Wallin K, Wiklund F, Angstrom T, [et al.]. Type-specific persistance of human papilloma virus DNA before the development of invasive cervical cancer. N Engl J Med. 1999, 341, 1633-1638.
45. Frega A, Stentella P, Spera G, [et al.]. Cervical intraepithelial neoplasia and bacterial vaginosis: correlation and risk factor? Eur J Gynoecol Oncol. 1997, 18, 76-77.
46. Anttila T, Saikku P, Koskela P, [et al.]. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA. 2001, 285, 47-51.
47. Komorowska A. Ginekologia wieku rozwojowego. Warszawa: PZWL. 2000, 221-231.
48. Baeten J, Nyange P, Richardson B, [et al.]. Hormonal contraception and risk of sexually transmitted disease acquistion: results from prospective study. Am J Obstet Gynecol. 2001, 185, 380-385.
49. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med. 1994, 331, 341-346.
50. d'Oro L, Parazzini F, Naldi L, [et al.]. Barrier methods of contraception, spermicides, and sexually transmitted diseases: a review. Genitourin Med. 1994, 70, 410-417.
51. Warner L, Newman D, Austin H, [et al.]. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol. 2004, 159, 242-251.
52. Woynarowska B, Izdebski Z, Kołoło H, [i wsp.]. Inicjacja seksualna i stosowanie prezerwatyw oraz innych metod zapobiegania ciaży przez młodzież15-letnia w Polsce i w innych krajach. Ginekol Pol. 2004, 75, 621-632.
53. Ness R, Soper D, Holley R, [et al.]. Hormonal and barrier contraception and risk of upper genital tract disease in the PID. Evaluation and Clinical Health (PEACH) study. Am J Obstet Gynecol. 2001, 185, 121-127.
54. McCormack W, Rosner B, McComb D, [et al.]. Infection with Chlamydia trachomatis in female college students. Am J Epidemiol. 1985, 121, 107-115.
55. Kinghorn G, Waugh M. Oral contraceptive use and prevalence of infection with Chlamydia trachomtis in women. Br J Vener Dis. 1981, 57, 187-190.
56. Shafer M, Beck A, Blain B, [et al.]. Chlamydia trachomatis important relationships to race, contraception, lower genital tract infection, and Papanicolaou smear. J Pediatr. 1984, 104, 141-146.
57. Louv W, Austin H, Perlman J, [et al.]. Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol. 1989, 160, 396-402.
58. Dajek Z. Leczenie jednorazowa doustna dawka azitromycyny niepowikłanych zakażeń cewki moczowej i szyjki macicy wywołanych przez Chlamydia trachomatis. Przegl Dermatol. 1996, 83, 545-550.